𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P060 OPEN-LABEL INFLIXIMAB THERAPY IN CROHN'S DISEASE: A LONG-TERM MULTICENTER STUDY OF EFFICACY, SAFETY AND PREDICTORS OF RESPONSE

✍ Scribed by Y. González-Lama


Book ID
119637047
Publisher
Oxford University Press
Year
2007
Weight
60 KB
Volume
1
Category
Article
ISSN
1873-9954

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy of infliximab in pediatric Croh
✍ Frank M. Ruemmele; Alain Lachaux; Jean-Pierre Cézard; Alain Morali; Chantal Maur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is efficacious in inducing remission in severe forms of pediatric crohn's disease (cd). adult studies indicate that ifx is also safe and well tolerated as maintenance therapy. the present study aimed to evaluate in a prospective manner the efficacy and safety of ifx